Table 2.
Classes of Medications with Discrepancies on SNF Admission
| Drug class | n | % of 495 medication discrepancies |
|---|---|---|
| Gastrointestinal agents1 | 77 | 15.6 |
| Cardiovascular agents2 | 63 | 12.7 |
| Opioid analgeics | 61 | 12.3 |
| Neuropsychiatric agents3 | 39 | 7.9 |
| Hypoglycemic agents | 38 | 7.7 |
| Anticoagulants5 | 34 | 6.9 |
| Antibiotic/antiinfective agents4 | 33 | 6.7 |
| Vitamins, minerals, and nutritional supplements6 | 31 | 6.3 |
| Asthma/allergy agents | 30 | 6.1 |
| Nonopioid analgesics7 | 21 | 4.2 |
| Hematologic agents | 16 | 3.2 |
| Osteoporosis agents8 | 16 | 3.2 |
| Topical agents9 | 11 | 2.2 |
| Endocrine agents10 | 7 | 1.4 |
| Unknown11 | 6 | 1.2 |
| Rheumatologic agents12 | 5 | 1.0 |
| Genitourinary agents13 | 4 | 0.8 |
| Complementary and alternative agents | 2 | 0.4 |
| Immunosuppressants14 | 1 | 0.2 |
1Antiemetics, stool softeners, anti-diarrheals, stool bulking agents, H2 blockers, proton pump inhibitors, laxatives, gastric coating agents, sulfasalazine
2ACE inhibitors, diuetics (loop, thiazide, potassium sparing), beta-blockers, nitrates, digoxin, calcium channel blockers, lipid-lowering agents
3Antidepressants, antiseizure agents, cholinesterase inhibitors, atypical antipsychotics, sedative/hypnotics
4Quinolones, azole antifungals, trimethoprim-sulfamethoxazole, cephalopsorins, erythromycin, imipenem/cilastin, metronidazole, vancomycin, macrolides, lactobacillus, abacavir
5Warfarin and antiplatelet agents
6Potassium supplements, fish oil, total parenteral nutrition
7Acetaminophen, propoxyphene, capsaicin cream, lidocaine patch, NSAIDs, tramadol, quinine
8Epopoetin, iron supplements, vitamin B12
9Dermatologic and ophthalmic agents
10Steroids, hormone replacement, calcitriol
11Drug name illegible or omitted
12Allopurinol and colchicine
13Anticholinergics (oxybutinin, solifenacin), alpha blockers
14Azathioprine